Cialis Shows Steady Growth in First Nine Months On the US ED Treatment Market

6 May, 2008 (23:01) | Uncategorized

Cialis(tadalafil) particular steadily increased its flea market measure and gain in opposition Viagra (sildenafil citrate) surrounded by the nine months since it be introduce in the U.S. to immoderation erectile dysfunction (ED). Recent survey reinforce that the prevalent focussed in favour of this improvement be because Cialis works for aloft to 36 hours, allowing a man and his partner juncture to rest, not disturb going on for planning and be intimate when they want to be.2 For the week terminated August 6, weekly exotic prescription information spectacular Cialis has 20.1 percent of new oral ED performance prescription in the U.S., compare to 14.1 percent for Levitra (vardenafil HCl) and 65.8 percent for Viagra.3 In total oral ED prescriptions, Cialis has 15.7 percent in the U.S., compared to 11.3 percent for Levitra and 73 percent for Viagra. Cialis has increased its share of total prescriptions all month since its preface in the U.S.4 According to the findings from two recent surveys, one flanking man who be person treat with Cialis and the other with physician who prescribe the commodities, which be sponsor by means of Lilly ICOS and conduct by Harris Interactive: Patient Survey (300 patients taking Cialis) Of men in the belief poll who indicate they ideal Cialis and have in earlier times personal other oral ED treatment, 81 percent stated they preferred Cialis deliberately because it works for capable of 36 hours.

In the survey, 77 percent of the men survey any agreed or firmly agreed with the pronouncement, “with Cialis, I don’t should worry about being intimate inside a unmistaken bout of time.” Physician Survey (202 artistic support physicians (PCPs) and 208 urologists who prescribe Cialis) The climax (81 percent) reason physicians surveyed indicated they recommended Cialis to their patients who have not try other oral ED treatments was that it works up to 36 hours.

An norm of 90 percent of doctors surveyed agreed or strongly agreed with the statement, “I prescribe Cialis to men with ED who quiver greater freedom from planning” (92 percent of 202 primary care physicians and 89 percent of 208 urologists).

An average of 97 percent of physicians surveyed suppose that their patients are “satisfied” to “extremely satisfied” with Cialis (96 percent of primary care physicians and 98 percent of urologists).

“These grades taking up what we are already seeing in market in the state of the world,” said Leonard Blum, vice president of marketing, ICOS Corporation. “Men and their doctors who are single out Cialis by means of their ED treatment are doing for that reason because of the distinctive attribute it offer patients.” In incorporation to utilizable up to 36 hours in maximum men, Cialis can be taken subsequent to an void tummy or with a spread, short kindness that high-fat necessities will cut back the digestion of the pills.

These benefits allow a man and his partner to relax and consent to intimacy rush back up when the jiffy is suitable for them.

About the Surveys The two surveys, sponsored by Lilly ICOS LLC, were conducted online by Harris Interactive involving June 3 and June 9, 2004. PCPs (202) and Urologists (208) who were all widespread Cialis prescribers were conscript from the Harris Interactive Physicians Panel via an email invitation, which outline the errand of the survey in usual language. Physicians were given an honorarium in trade off for their link.

The merciful allusion was recruited from the Harris Interactive Chronic Illness and general panel. To qualify for this survey, patient respondents had to gain both the requirements of being manly between the ages of 40 and 70 years, be a U.S. resident, have erectile dysfunction and be taking Cialis.

Data from the physicians’ sample were unweighted and data from the patients’ sample were weighted for age, sexual characteristics, race/ethnicity, childhood, possessions, transcendent being and affinity to be online to align them with population proportions. In hypothesis, with likelihood sample of this decibels, one could right to be hear with 90 percent authority that the results have a sampling steal of plus or minus seven percentage barb of what they would be if the total U.S. online population of PCPs and urologists who at present prescribe Cialis to patients OR the total U.S. population of men who currently nick Cialis for ED had be surveyed with entire carefulness. These online samples were not probability samples.

About Cialis Cialis, certified by the FDA in November 2003 for the treatment of erectile dysfunction, is the one and only oral ED treatment shown to promote erectile activate up to 36 hours in most men. Cialis can be taken without high regard to food. The absorption of Cialis is not reduced by food, as well as high-fat food. Cialis is currently uncommitted in nearly 90 country, including Australia, Brazil, Mexico, Canada, the United States and countries for the duration of Europe. Nearly three million patients entire have been treated with Cialis since its early introduction in February 2003.

The ingenious Global Animal Health Conference, mutually organised via the European Medicines Agency (EMEA) and the International Federation surrounded by assistance of Animal Health (IFAH), in conjunction beside the Drug Information Association, (DIA), will seize lodge at the EMEA by 15-16 November 2007 in London, UK.

More studies are arranged to investigate whether these results can have clinical implementations.

The most common on the side effects with Cialis were headache, distraught stomach, delayed backache and muscle twinge. Although intermittent, men who stir through an erection for beyond four hours should want immediate medical attention. Men should not paint the town red alcohol in hyperbole with Cialis. Cialis study were not designed to judge multiple intercourse attempt after a isolated dose.

For stuffed patient facts, drop in About ED ED is defined as the unvarying inability to realize and hold up an erection generous for sexual intercourse. ED affect an inexact 152 million men and their partner worldwide.5 Experts believe that 80 - 90 percent of ED cases are correlated to a natural or medical if, resembling diabetes, cardiovascular virus, and prostate cancer treatment, while 10 - 20 percent are in the red to psychological cause.6,7 In plentiful cases, otherwise, both psychological and physical factor share to the condition.8 About Lilly ICOS LLC Lilly ICOS LLC, a united activity between ICOS Corporation (Nasdaq: ICOS) and Eli Lilly and Company (NYSE: LLY), urban tadalafil for the treatment of erectile dysfunction.

Lilly, a chief innovation-driven multinational is sprouting a escalating portfolio of first-in-class and best-in-class pharmaceutical products by apply the most modern research from its own worldwide laboratories and from collaboration with inner self above you reckonable humanity.

Headquartered in Indianapolis, Ind., Lilly afford answers - through medicine and information - for a few of the world’s most vital medical requests. Additional information about Lilly is available at ICOS Corporation, a biotechnology people, is unswerving to moving advanced therapeutics to patients. Headquartered in Bothell, Washington, ICOS is marketing its first product, Cialis (tadalafil), for the treatment of erectile dysfunction. ICOS is working to exchange treatments for important unmet medical provisos such as persistent obstructive pulmonary disease, benign prostatic hyperplasia, cancer and inflammatory diseases.

Except for historical information contained herein, this pinch secretion contain forward-looking statement within the characterization of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are foundation on current expectations, assumption and projection about the industry, dictate idea and certain presupposition made by the management of ICOS and Lilly. Investors are caution that matter proposal to forward-looking statements mix up with venture and uncertainties, including fiscal, ruthless, governmental, scientific, officially familiar and other factors discuss in the two companies’ respective filings with the Securities and Exchange Commission, which may affect the commercial and prospects of the two company and Lilly ICOS. Results and the time and termination results of engagements may rebut materially from those expressed or implied by the forward-looking statements here press release. More specifically, in that can be no promise that Cialis will engage in commercial glory or that enemy products will not pre-empt market opportunity that imaginably will be alive for the product.

Key Findings A1C reduction: — Both treatment group achieved similar HbA1C reduction. Exenatide lower HbA1C by 1.04 percent while biphasic insulin aspart lowered HbA1C by 0.89 percent.

2. Individual results may change. Not studied for multiple attempts per dose.

3. IMS National Prescription Audit Plus7 August 2004.

4. IMS National Prescription Audit Plus June 2004 5. Aytac Ia, McKinlay JB, Krane RJ. The Likely Worldwide Increase in Erectile Dysfunction Between 1995 and 2025 and Some Possible Policy Consequences. BJU Int 1999; 84: 50-56.

6. Shabsigh, R. (2002). Back To Great Sex: Overcome ED and Reclaim Lost Intimacy . New York: Kensington.

7. Diseases and Conditions: Impotence, /FAQ/index.asp. Data access 11.20.03 8. Lue, Tom F. Erectile Dysfunction. N Engl J Med 2000; 342: 1802-1813

Write a comment





*
To prove you're a person (not a spam script),
please type the security word shown in the picture.

Anti-Spam Image


This Site is Ranked # 9 at BlogSites.in

Top 20 Blog Sites | Get A Free Blog | All Top Blog Sites


Click Here to Report Spam, Offensive Content, or Other Problems with This Blog Site